Download video

Chemo-IO Over IO Alone in Patients With Advanced NSCLC - Medpage Today

48 views

MedPage Today

3 years ago

Chemo-IO Over IO Alone in Patients With Advanced NSCLC - Medpage Today

Chemo-IO Over IO Alone in Patients With Advanced NSCLC - Medpage Today

Chemo-IO Over IO Alone in Patients With Advanced NSCLC - Medpage Today
11:09
Chemo-IO Over IO Alone in Patients With Advanced NSCLC - Medpage Today
by MedPage Today
Is Immunotherapy Combo a Better Option in Advanced NSCLC? - Medpage Today
4:58
Is Immunotherapy Combo a Better Option in Advanced NSCLC? - Medpage Today
by MedPage Today
What Did We Learn From IMpower010 in Resectable NSCLC? - Medpage Today
21:02
What Did We Learn From IMpower010 in Resectable NSCLC? - Medpage Today
by MedPage Today
Immunotherapy-Chemo Offers Survival Advantage in Low PD-L1 NSCLC - Medpage Today
1:21
Immunotherapy-Chemo Offers Survival Advantage in Low PD-L1 NSCLC - Medpage Today
by MedPage Today
Is Disease-Free Survival a Meaningful Endpoint in NSCLC? - Medpage Today
4:44
Is Disease-Free Survival a Meaningful Endpoint in NSCLC? - Medpage Today
by MedPage Today
MET Inhibitor Rescues Some Targeted Tx Failures in NSCLC - Medpage Today
3:39
MET Inhibitor Rescues Some Targeted Tx Failures in NSCLC - Medpage Today
by MedPage Today
ESMO: First-Line Erlotinib Improves NSCLC Outcomes
3:01
ESMO: First-Line Erlotinib Improves NSCLC Outcomes
by MedPage Today
Early Palliative Care Boosts Survival in NSCLC
3:12
Early Palliative Care Boosts Survival in NSCLC
by MedPage Today
ASCO Roundtable: Lung Cancer Highlights - Medpage Today
15:32
ASCO Roundtable: Lung Cancer Highlights - Medpage Today
by MedPage Today
ASCO: Erbitux Gives Extra Time to Advanced Lung Cancer
3:59
ASCO: Erbitux Gives Extra Time to Advanced Lung Cancer
by MedPage Today
ADAURA: Extremely Positive Data in Early NSCLC, but Questions Remain - Medpage Today
6:05
ADAURA: Extremely Positive Data in Early NSCLC, but Questions Remain - Medpage Today
by MedPage Today
What the New KRAS Inhibitor Means for Lung Cancer - Medpage Today
10:45
What the New KRAS Inhibitor Means for Lung Cancer - Medpage Today
by MedPage Today
Adjuvant and neoadjuvant chemo-IO for UK patients with NSCLC
1:48
Adjuvant and neoadjuvant chemo-IO for UK patients with NSCLC
by VJOncology
ASCO: Genes Guide Early Stage NSCLC Treatment Decisions
3:46
ASCO: Genes Guide Early Stage NSCLC Treatment Decisions
by MedPage Today
Management of patients with PDL1-high advanced NSCLC
4:23
Management of patients with PDL1-high advanced NSCLC
by VJOncology
Almost Half of Lung Cancer Patients Still Smoked After Surgery - Medpage Today
4:30
Almost Half of Lung Cancer Patients Still Smoked After Surgery - Medpage Today
by MedPage Today
IMpower133: Real-World vs Clinical Trial Data in SCLC - Medpage Today
3:42
IMpower133: Real-World vs Clinical Trial Data in SCLC - Medpage Today
by MedPage Today
Chemo-IO, IO-IO, or IO-mono: which is correct for lung cancer?
3:15
Chemo-IO, IO-IO, or IO-mono: which is correct for lung cancer?
by VJOncology
Chemotherapy-free immunotherapy-based treatment approaches for NSCLC
0:48
Chemotherapy-free immunotherapy-based treatment approaches for NSCLC
by VJOncology